Search Within

ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS
Results 1 - 50 of 50

The Application of Angiotensin Converting Enzyme Inhibitors in Heart Surgery

Journal: Letters in Drug Design & Discovery
Volume: 2,Issue: 2
Page: 105-108
Authors: Yasuyuki Shimada

Radioligands for the Angiotensin II Subtype 1 (AT1) Receptor

Journal: Current Topics in Medicinal Chemistry
Volume: 10,Issue: 1
Page: 1585-1599
Authors: William B. Mathews and Zsolt Szabo

Aliskiren: A Novel Renin Inhibitor for Hypertension

Journal: Current Drug Therapy
Volume: 2,Issue: 3
Page: 236-239
Authors: Vandana Tayal and Bhupinder Singh Kalra

Substituted Benzimidazole Derivatives as Angiotensin II -AT1 Receptor Antagonist: A Review

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 10,Issue: 1
Page: 1366-1384
Authors: V. K. Vyas and M. Ghate

Pharmacological Implications of MMP-9 Inhibition by ACE Inhibitors

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 1
Page: 1349-1354
Authors: Daisuke Yamamoto and Shinji Takai

Exploring Structure-based Drug Design for the Development of Multitarget Antihypertensives

Journal: Letters in Drug Design & Discovery
Volume: 12,Issue: 9
Page: 704-710
Authors: Estella G. da Mota, Elaine F. F. da Cunha and Matheus P. Freitas

The Therapeutic Role of Renin-Angiotensin System Blockers in Obesity- Related Renal Disorders

Journal: Current Clinical Pharmacology
Volume: 9,Issue: 1
Page: 2-9
Authors: Sergio Henrique Sousa Santos and Ana Cristina Simoes e Silva

Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 4,Issue: 2
Page: 75-78
Authors: Akira Miyajima, Eiji Kikuchi, Takeo Kosaka and Mototsugu Oya

Blockade of the Renin-Angiotensin-Aldosterone System: Effects on Hypertensive Target Organ Damage

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 4,Issue: 3
Page: 219-228
Authors: Anna M Grandi and Andrea M. Maresca

Angiotensin Converting Enzyme Inhibitors and Cardiopulmonary Bypass: Is ACE Inhibitor Safe for Heart Surgery?

Journal: Current Enzyme Inhibition
Volume: 1,Issue: 3
Page: 253-256
Authors: Yasuyuki Shimada and Hideshi Itoh

Ectopic Fat Storage, Insulin Resistance, and Hypertension

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 2
Page: 3074-3080
Authors: Anna Maria Sironi, Rosa Sicari, Franco Folli and Amalia Gastaldelli

Angiotensin Converting Enzyme Inhibitor in Coronary Artery Bypass Surgery

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 2,Issue: 7
Page: 495-500
Authors: Yasuyuki Shimada and Fumio Yamamoto

Oxidative Stress in Cardiovascular Disease: A New Avenue Toward Future Therapeutic Approaches

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 1,Issue: 2
Page: 151-159
Authors: Reiko Inagi

Stage B: What is the Evidence for Treatment of Asymptomatic Left Ventricular Dysfunction?

Journal: Current Cardiology Reviews
Volume: 11,Issue: 1
Page: 18-22
Authors: Brent N. Reed and Carla A. Sueta


Angiotensin II Type I Receptor Blocker and Endothelial Function in Humans: Role of Nitric Oxide and Oxidative Stress

Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 3,Issue: 2
Page: 133-148
Authors: Yukihito Higashi, Kazuaki Chayama and Masao Yoshizumi

Pharmacological, Immunological, and Gene Targeting of the Renin-Angiotensin System for Treatment of Cardiovascular Disease

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 1
Page: 1199-1214
Authors: Rajko Igic and Rahim Behnia

Interaction Between Genetic Polymorphisms in Renin-Angiotensin System (RAS) and Therapeutic Efficacy of RAS Blockade in IgA Nephropathy

Journal: Current Pharmacogenomics
Volume: 2,Issue: 2
Page: 157-162
Authors: I. Narita and F. Gejyo

Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 2
Page: 3133-3145
Authors: Huige Li and Ulrich Forstermann

New Challenges for ACE-Inhibitors in Vascular Diseases

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 2,Issue: 7
Page: 485-493
Authors: Claudio Napoli and Joseph Loscalzo

Effects of ACE Inhibitors on Skeletal Muscle

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 1
Page: 2057-2064
Authors: Graziano Ondera, Cecilia D. Vedova and Marco Pahorc

Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions

Journal: Current Vascular Pharmacology
Volume: 4,Issue: 3
Page: 253-268
Authors: Eva Lonn and Jasmine Grewal

Congestive Heart Failure: Pharmacological Agents and the Potential of BType Natriuretic Peptide

Journal: Current Medicinal Chemistry
Volume: 12,Issue: 1
Page: 1439-1447
Authors: Kenneth D. James, Alessandro Cataliotti, John A. Schirger, Shannon Plonka and John C. Burnett Jr

Gender Differences in Chronic Cough

Journal: Current Respiratory Medicine Reviews
Volume: 7,Issue: 1
Page: 40-46
Authors: Masaki Fujimura

Inflammation in Atherosclerosis: A New Therapeutic Target

Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 4,Issue: 3
Page: 283-295
Authors: H. N. Skouri, P. A. Zalloua and A. B. Abchee

Large A-V Fistula: Pathophysiological Consequences and Therapeutic Perspectives

Journal: Current Vascular Pharmacology
Volume: 1,Issue: 3
Page: 347-354
Authors: Zaid A. Abassi, Joseph Winaver and Aaron Hoffman

Cardiovascular Drugs and Bone

Journal: Current Drug Safety
Volume: 3,Issue: 3
Page: 178-184
Authors: Lars Rejnmark

Direct Renin Inhibition: Promising Treatment in Renoprotection?

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 5,Issue: 2
Page: 113-119
Authors: Giacomina Loriga

Prevention of Macrovascular Disease in Type 2 Diabetic Patients: Blockade of the Renin-Angiotensin-Aldosterone System

Journal: Current Diabetes Reviews
Volume: 4,Issue: 1
Page: 63-78
Authors: G. Neil Thomas and Brian Tomlinson

The ONTARGET Trial Programme: Facts and Lessons

Journal: Current Hypertension Reviews
Volume: 5,Issue: 3
Page: 202-209
Authors: Thomas Unger, Ulrich Kintscher, Kai Kappert and Ulrike M. Steckelings

A Novel Design of Combining the Angiotensin Converting Enzyme (ACE) Inhibitor Captopril with the Angiotensin Receptor Blocker (ARB) Losartan Using Homo Coupling via PEG Diacid Linker

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 8,Issue: 3
Page: 221-225
Authors: Mehrnoosh Hashemzadeh, Shery Park, Hee Ju and Mohammad R. Movahed

Genes, Environment, Intermediate Phenotypes, and the Pathogenesis of Diabetic Nephropathy

Journal: Current Pharmacogenomics
Volume: 2,Issue: 1
Page: 61-74
Authors: M. C. Lansang and N. K. Hollenberg

Impact of Inhibitors of the Renin-Angiotensin-Aldosterone System on Liver Fibrosis and Portal Hypertension

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 3
Page: 3649-3661
Authors: U. Tox and H. M. Steffen

Renin-angiotensin System Blockade at the Level of the Angiotensin Converting Enzyme or the Angiotensin Type-1 Receptor: Similarities and Differences

Journal: Current Topics in Medicinal Chemistry
Volume: 4,Issue: 4
Page: 473-481
Authors: George S. Stergiou and Irini I. Skeva

Endothelial Progenitor Cells Dysfunction and Senescence: Contribution to Oxidative Stress

Journal: Current Cardiology Reviews
Volume: 4,Issue: 4
Page: 275-286
Authors: Toshio Imanishi, Hiroto Tsujioka and Takashi Akasaka

Impact of Chronic Kidney Disease on Risk for Vascular Events

Journal: Current Vascular Pharmacology
Volume: 14,Issue: 5
Page: 409-414
Authors: Jerry Fan and Hasan Salameh

The Renin-Angiotensin System: The Role of Inhibitors, Blockers, and Genetic Polymorphisms in the Treatment and Prevention of Heart Failure

Journal: Current Vascular Pharmacology
Volume: 1,Issue: 1
Page: 33-39
Authors: Patricia R. Hebert, JoAnne M. Foody and Charles H. Hennekens

Chronic Inhibition of Na+/H+-Exchanger in the Heart

Journal: Current Vascular Pharmacology
Volume: 4,Issue: 1
Page: 23-29
Authors: Antonius Baartscheer

Renin Angiotensin System and Cytokines in Chronic Kidney Disease: Clinical and Experimental Evidence

Journal: Protein & Peptide Letters
Volume: 24,Issue: 9
Page: 799-808
Authors: Ariadna Andrade Saldanha da Silva, Thiago Ruiz Rodrigues Prestes, Amanda Oliveira Lauar, Bernardo Bahia Finotti and Ana Cristina Simoes e Silva*

Angiotensin-Converting Enzyme Inhibitors in Veterinary Medicine

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 1
Page: 1347-1361
Authors: H. P. Lefebvre, S. A. Brown, V. Chetboul, J. N. King, J.-L. Pouchelon and P. L. Toutain

The Future of Angiotensin II Inhibition in Cardiovascular Medicine

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 5,Issue: 1
Page: 15-30
Authors: Pascal Meier, Marc Maillard and Michel Burnier

Safety and Efficacy of Aliskiren in the Treatment of Hypertension and Associated Clinical Conditions

Journal: Current Drug Safety
Volume: 7,Issue: 1
Page: 76-85
Authors: Fabio Angeli, Gianpaolo Reboldi, Giovanni Mazzotta, Cristina Poltronieri, Marta Garofoli, Elisa Ramundo, Alessandra Biadetti and Paolo Verdecchia

Efficacy and Safety Profile of Aliskiren: Practical Implications for Clinicians

Journal: Current Drug Safety
Volume: 9,Issue: 2
Page: 106-117
Authors: Fabio Angeli, Gianpaolo Reboldi, Cristina Poltronieri, Enrica Angeli, Valentina De Filippo, Alessandra Crocetti, Claudia Bartolini, Cinzia D'Ambrosio and Paolo Verdecchia

Mechanisms of Fetal and Neonatal Renal Impairment by Pharmacologic Inhibition of Angiotensin

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 2
Page: 4572-4580
Authors: Robert L. Chevalier

Aliskiren in Patients with Diabetes: A Systematic Review

Journal: Current Vascular Pharmacology
Volume: 10,Issue: 2
Page: 140-146
Authors: Evangelos C. Rizos, Aris P. Agouridis and Moses S. Elisaf

Medical Management of the Diabetic Patient with Coronary Artery Disease

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 2
Page: 2527-2536
Authors: Kalypso Karastergiou and Juan Carlos Kaski

Effect of an Angiotensin II Receptor Blocker and Two Angiotensin Converting Enzyme Inhibitors on Transforming Growth Factor-β (TGF-β) and α-Actomyosin (α SMA), Important Mediators of Radiation-Induced Pneumopathy and Lung Fibrosis

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 1
Page: 1307-1316
Authors: Agostino Molteni, Lisa F. Wolfe, William F. Ward, C. Hsin Ts'ao, Loredana Brizio Molteni, Patricia Veno, Brian L. Fish, Joan M. Taylor, Norma Quintanilla, Betty Herndon and John E. Moulder

Cytostatic Properties of Some Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type I Receptor Antagonists

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 9
Page: 751-761
Authors: Agostino Molteni, William F. Ward, Chung H. Ts'ao, JoAnn Taylor, William Small Jr., Loredana Brizio-Molteni and Patricia A. Veno

Molecular Counting of Captopril by a Microfluidic Chip-Thermal Lens Microscopy System

Journal: Current Analytical Chemistry
Volume: 13,Issue: 6
Page: 508-514
Authors: Atefeh Abbasi-Ahd, Nader Shokoufi* and Kazem Kargosha

Results 1 - 50 of 50